MLN4924 (Pevonedistat), a protein neddylation inhibitor, suppresses proliferation and migration of human clear cell renal cell carcinoma
Author:
Publisher
Springer Science and Business Media LLC
Subject
Multidisciplinary
Link
http://www.nature.com/articles/s41598-017-06098-y.pdf
Reference43 articles.
1. Ferlay, J. et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. International journal of cancer 136, E359–386, doi: 10.1002/ijc.29210 (2015).
2. American Cancer sociey. Cancer Facts & Figures 2015,. Special Se, 26, www.cancer.org .
3. Heng, D. Y. & Choueiri, T. K. Non-clear cell renal cancer: features and medical management. Journal of the National Comprehensive Cancer Network: JNCCN 7, 659–665 (2009).
4. Golovastova, M. O. et al. Biomarkers of Renal Tumors: the Current State and Clinical Perspectives. Current urology reports 18, 3, doi: 10.1007/s11934-017-0655-1 (2017).
5. Dos Santos, M., Brachet, P. E., Chevreau, C. & Joly, F. Impact of targeted therapies in metastatic renal cell carcinoma on patient-reported outcomes: Methodology of clinical trials and clinical benefit. Cancer treatment reviews 53, 53–60, doi: 10.1016/j.ctrv.2016.12.003 (2016).
Cited by 55 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Development of 4′-Oxo-MLN4924 as potential neddylation inhibitors: Design, synthesis, anti-HCMV evaluation, and molecular docking;Results in Chemistry;2024-10
2. HDAC3 genetic and pharmacologic inhibition radiosensitizes fusion positive rhabdomyosarcoma by promoting DNA double-strand breaks;Cell Death Discovery;2024-08-06
3. Protein neddylation and its role in health and diseases;Signal Transduction and Targeted Therapy;2024-04-05
4. Protein Stability Regulation in Osteosarcoma: The Ubiquitin-like Modifications and Glycosylation as Mediators of Tumor Growth and as Targets for Therapy;Cells;2024-03-18
5. ncRNAs Orchestrate Chemosensitivity Induction by Neddylation Blockades;Cancers;2024-02-18
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3